<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03069456</url>
  </required_header>
  <id_info>
    <org_study_id>CNUHH-2015-067</org_study_id>
    <nct_id>NCT03069456</nct_id>
  </id_info>
  <brief_title>Comparative Population Pharmacodynamic Modeling for Sevoflurane Effects Using ADMS and Bispectral Index</brief_title>
  <official_title>Comparative Population Pharmacodynamic Modeling for Sevoflurane Effects Using Anesthetic Depth Monitoring for Sedation (ADMS) and Bispectral Index System (BIS)</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Chonnam National University Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Chonnam National University Hospital</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The investigators want to compare the performance of anesthetic depth monitoring for sedation
      (ADMS) to the bispectral index (BIS) as electroencephalographic measures of sevoflurane
      effect using two combined sigmoidal Emax models via population pharmacodynamic approach.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Intraoperative awareness under general anesthesia is rare, but it may cause serious
      psychological sequelae. Anesthetic depth monitoring system based on
      electroencephalography(EEG) or evoked potential are broadly used methods. Bispectral index
      (BIS) monitor is most popular anesthetic depth monitoring system. Anesthetic depth monitoring
      for sedation (ADMS) is developed in Korea as an electroencephalographic monitor for measuring
      the depth of anesthesia. The investigators want to compare the performance of ADMS to the
      bispectral index (BIS) as electroencephalographic measures of sevoflurane effect using two
      combined sigmoidal Emax models via population pharmacodynamic approach.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date>April 2016</start_date>
  <completion_date type="Anticipated">December 2017</completion_date>
  <primary_completion_date type="Anticipated">June 2017</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Crossover Assignment</intervention_model>
    <intervention_model_description>Combined sigmoidal Emax models from anesthetic depth monitoring for sedation (ADMS) and combined sigmoidal Emax models from bispectral index (BIS) via population pharmacodynamic approach.</intervention_model_description>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Bispectral Index (BIS)</measure>
    <time_frame>Data capture will be started 45 minutes after induction of general anesthesia for 70 minutes</time_frame>
    <description>captured BIS data (0~100) from the BIS system after induction of general anesthesia, sevoflurane concentrations will be progressively increased and then decreased over 70 min.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Anesthetic depth monitoring for sedation (ADMS)</measure>
    <time_frame>Data capture will be started 45 minutes after induction of general anesthesia for 70 minutes</time_frame>
    <description>captured ADMS data (0~100) from the ADMS system after induction of general anesthesia, sevoflurane concentrations will be progressively increased and then decreased over 70 min.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Adverse events</measure>
    <time_frame>visit patients 24 hours after operation.</time_frame>
    <description>Observe all adverse events both groups</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">30</enrollment>
  <condition>Anesthesia</condition>
  <arm_group>
    <arm_group_label>BIS group</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Combined sigmoidal Emax models from the BIS data</description>
  </arm_group>
  <arm_group>
    <arm_group_label>ADMS group</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Combined sigmoidal Emax models from the ADMS data</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>BIS</intervention_name>
    <arm_group_label>BIS group</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>ADMS</intervention_name>
    <arm_group_label>ADMS group</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  adult patients scheduled for an elective operation and postoperative epidural PCA with
             ASA physical status 1,2,3 who have signed the wrtten informed consent.

        Exclusion Criteria:

          -  preventive anticoagulation treatment

          -  Significant liver, kidney, coagulation dysfunction

          -  Clinically significant ECG abnormalities

          -  administration of psychologic durgs or opioid within 14 days before surgery
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>20 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>SEONGWOOK JEONG, MD, PhD.</last_name>
    <role>Principal Investigator</role>
    <affiliation>Chonnam National University Hospital</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Tae-hee Pyeon, MD</last_name>
    <phone>+82-10-2705-9901</phone>
    <email>skybluevus@naver.com</email>
  </overall_contact>
  <location>
    <facility>
      <name>Chonnam National University Hwasun Hospital</name>
      <address>
        <city>Hwasun</city>
        <zip>519-763</zip>
        <country>Korea, Republic of</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Chanhong Park</last_name>
      <phone>+82-61-379-7598</phone>
      <email>cnuhpch@naver.com</email>
    </contact>
  </location>
  <location_countries>
    <country>Korea, Republic of</country>
  </location_countries>
  <reference>
    <citation>Han DW, Linares-Perdomo OJ, Lee JS, Kim JH, Kern SE. Comparison between cerebral state index and bispectral index as measures of electroencephalographic effects of sevoflurane using combined sigmoidal E(max) model. Acta Pharmacol Sin. 2011 Oct;32(10):1208-14. doi: 10.1038/aps.2011.99. Epub 2011 Sep 5.</citation>
    <PMID>21892201</PMID>
  </reference>
  <reference>
    <citation>Kreuer S, Bruhn J, Wilhelm W, Grundmann U, Rensing H, Ziegeler S. Comparative pharmacodynamic modeling of desflurane, sevoflurane and isoflurane. J Clin Monit Comput. 2009 Oct;23(5):299-305. doi: 10.1007/s10877-009-9196-6. Epub 2009 Aug 27.</citation>
    <PMID>19711188</PMID>
  </reference>
  <reference>
    <citation>Rehberg B, Bouillon T, Zinserling J, Hoeft A. Comparative pharmacodynamic modeling of the electroencephalography-slowing effect of isoflurane, sevoflurane, and desflurane. Anesthesiology. 1999 Aug;91(2):397-405.</citation>
    <PMID>10443602</PMID>
  </reference>
  <verification_date>February 2017</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>February 15, 2017</study_first_submitted>
  <study_first_submitted_qc>February 27, 2017</study_first_submitted_qc>
  <study_first_posted type="Actual">March 3, 2017</study_first_posted>
  <last_update_submitted>February 27, 2017</last_update_submitted>
  <last_update_submitted_qc>February 27, 2017</last_update_submitted_qc>
  <last_update_posted type="Actual">March 3, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Chonnam National University Hospital</investigator_affiliation>
    <investigator_full_name>Seongwook Jeong</investigator_full_name>
    <investigator_title>professor</investigator_title>
  </responsible_party>
  <keyword>sevoflurane</keyword>
  <keyword>Bistpectral index</keyword>
  <keyword>Anesthetic Depth Monitoring System</keyword>
  <keyword>population pharmacodynamics</keyword>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Anesthetics</mesh_term>
    <mesh_term>Sevoflurane</mesh_term>
  </intervention_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

